Showing results (31-40 of 242) with videos related to
Sort By:
Pageof 25
Seminars in Oncology|November 8, 2002
Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancerPaul A Bunn, Wilbur FranklinThe Oncologist|March 8, 2008
Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. IntroductionPaul A Bunn, Nick ThatcherSeminars in Oncology|May 23, 2002
Future directions in the development of pemetrexedHilary Calvert, Paul A BunnFuture Oncology (London, England)|March 25, 2006
Clinical activity of pemetrexed: a multitargeted antifolate anticancer agentBenjamin Solomon, Paul A BunnJournal of Thoracic Disease|December 7, 2020
Changing paradigm in advanced and metastatic non-small cell lung cancerDipesh Uprety, Kaushal Parikh, Anita Sawkar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2022
Adjuvant Osimertinib in EGFR-Mutant Early-Stage NSCLC: Does HRQoL Influence Decisions?Tejas Patil, Paul A BunnCancer Investigation|July 7, 2007
Adjuvant chemotherapy for non-small cell lung cancerBenjamin Solomon, Paul A BunnThe Oncologist|March 8, 2008
Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. ConclusionPaul A Bunn, Nick ThatcherLeukemia & Lymphoma|March 18, 2014
The effect of calcium channel blockers on the outcome of acute myeloid leukemiaYoung Kwang Chae, Anastasios Dimou, Sherry Pierce, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Targeting the epidermal growth factor receptor in non-small cell lung cancerRoy S Herbst, Paul A BunnPageof 25